Surviving crises
as filed7.5/10
Has it survived what it has been through?
No warning events in its filings since 2017.
weight 33% of this tense · 75th percentile among 77 sector filers · read for itself
From the record
Hinge Health, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Track record
as filed6.3/10
What has it actually done, year after year?
+41.7% a year over 3 filed years; profitable in 0 of 3.
weight 45% of this tense · 63rd percentile among 64 sector filers · read for its customers
From the record
Hinge Health, Inc.'s 3 filed years say what it did: revenue went from $293 million in fiscal 2023 to $588 million in fiscal 2025, up 41.7% a year; it rose in 2 of 2 years; it never fell from a peak; net income was positive in 0 of 3 of those years (its annual reports).
What it rests on
- revenue growth over the filed span41.7%top 18% of its family
- the share of years revenue rosetop 21% of its family
- the share of filed years with a profitbottom 12% of its family
- the deepest fall from a revenue peak0.0%top 21% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Shareholder treatment
as filed3.4/10
How has it treated the people who own it?
Share count grew 104.7% a year. 42% of cash flow returned. Insiders: 165 sales, 0 purchases.
weight 22% of this tense · 34th percentile among 43 sector filers · read for its shareholders
From the record
Over the 2 fiscal years to 2025-12-31, Hinge Health, Inc.'s diluted share count grew about 104.7% a year, and dividends and buybacks returned about 42% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 165 sales (111 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-13 (their Form 4 filings).
What it rests on
- the share count over the yearsbottom 5% of its family
- cash returned against operating cash flowtop 37% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.